Literature DB >> 16442758

The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying.

W L J Hinrichs1, F A Manceñido, N N Sanders, K Braeckmans, S C De Smedt, J Demeester, H W Frijlink.   

Abstract

In a previous study we have shown that the oligosaccharide inulin can prevent aggregation of poly(ethylene glycol) (PEG) coated plasmid DNA/cationic liposome complexes ("PEGylated lipoplexes") during freeze thawing and freeze drying [Hinrichs et al., 2005. J. Control. Release 103, 465]. By contrast, dextran clearly failed as stabilizer. These results were ascribed to the fact that inulin and PEG are compatible while dextran and PEG are not. In this study the stabilizing capacities of inulin and dextran (of various molecular weights) during freeze thawing and freeze drying of four different types of nanoparticles, each type with different amounts of PEG at their surface, were investigated. Freeze drying and freeze thawing of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)/dioleoyl-phosphatidyl-ethanolamine (DOPE) liposomes and egg phosphatidyl choline (EPC)/cholesterol (CHOL) liposomes showed that inulins are excellent stabilizers even for highly PEGylated liposomes while (especially higher molecular weight) dextrans dramatically lost their stabilizing capacity when increasing the degree of PEGylation of the liposomes. The same results were obtained for plasmid DNA/DOTAP/DOPE complexes. Finally, both inulin and dextran could prevent full aggregation of plasmid DNA/polyethylenimine (PEI) complexes independent whether PEI was PEGylated or not. It is concluded that inulins are preferred as stabilizers over dextrans for various types of PEGylated nanoparticles due to their compatibility with PEG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442758     DOI: 10.1016/j.ijpharm.2005.12.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

1.  Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel.

Authors:  Eun-Hye Lee; Soon-Seok Hong; So Hee Kim; Mi-Kyung Lee; Joon Seok Lim; Soo-Jeong Lim
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

2.  Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.

Authors:  Lingli Zhou; Liu Yang; Chulei Yang; Yi Liu; Qiuyue Chen; Wenli Pan; Qing Cai; Lifeng Luo; Lu Liu; Shan Jiang; Haibing He; Yu Zhang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-05-23       Impact factor: 4.200

3.  Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability.

Authors:  Yinghuan Li; Jie Wang; Yue Gao; Jiabi Zhu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2011-09-10       Impact factor: 4.009

4.  Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

Authors:  Okhil K Nag; Vivek R Yadav; Andria Hedrick; Vibhudutta Awasthi
Journal:  Int J Pharm       Date:  2013-02-16       Impact factor: 5.875

5.  Nanoparticles of polyethylene sebacate: a new biodegradable polymer.

Authors:  Swati A Guhagarkar; Vinod C Malshe; Padma V Devarajan
Journal:  AAPS PharmSciTech       Date:  2009-07-24       Impact factor: 3.246

Review 6.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

7.  A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia.

Authors:  Zhaogang Yang; Bo Yu; Jing Zhu; Xiaomeng Huang; Jing Xie; Songlin Xu; Xiaojuan Yang; Xinmei Wang; Bryant C Yung; L James Lee; Robert J Lee; Lesheng Teng
Journal:  Nanoscale       Date:  2014-07-08       Impact factor: 7.790

8.  Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.

Authors:  Arehalli S Manjappa; Peeyush N Goel; Makam P Vekataraju; Kesarla S Rajesh; Kinjal Makwana; Mukesh Ukawala; Yuvraj Nikam; Rajiv P Gude; Rayasa S Ramachandra Murthy
Journal:  Pharm Res       Date:  2013-06-12       Impact factor: 4.200

9.  Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells.

Authors:  Abdulgader Baoum; Navneet Dhillon; Shilpa Buch; Cory Berkland
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

Review 10.  Fructan and its relationship to abiotic stress tolerance in plants.

Authors:  David P Livingston; Dirk K Hincha; Arnd G Heyer
Journal:  Cell Mol Life Sci       Date:  2009-03-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.